Syneos Health, Inc. Stock
Equities
SYNH
US87166B1026
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Colin Shannon
CEO | Chief Executive Officer | 65 | 23-09-27 |
Michael Bonello
DFI | Director of Finance/CFO | 55 | 23-06-30 |
Michael Brooks
COO | Chief Operating Officer | 50 | 21-07-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 23-09-27 |
Colin Shannon
CEO | Chief Executive Officer | 65 | 23-09-27 |
James Dimitri
BRD | Director/Board Member | - | 23-09-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.82% | 8 M€ | -.--% | ||
0.77% | 2 M€ | +6.77% | ||
0.50% | 0 M€ | 0.00% | - | |
0.36% | 0 M€ | 0.00% | - |
1st Jan change | Capi. | |
---|---|---|
+22.81% | 46.81B | |
+47.02% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |